While the COVID-19 pandemic exacerbated pharmaceutical supply chain challenges, pervasive drug shortages are the result of marketplace dynamics and cracks in the supply chain that originated long ago.

This inaugural edition of INSCRIPT, a new thought leadership publication from Premier’s Pharmacy experts, provides insights and recommendations for how regulators, manufacturers, distributors, purchasing groups and providers can manage and mitigate future drug shortages. 

Key features include:

• Detailed recommendations: building drug supply chain resiliency
• Premier member case studies
• Data-driven approach to drug shortage preparedness
• And more

For decades, Premier and its members have taken a leadership role in preventing and resolving drug shortages ─ bringing innovative solutions to the marketplace with a keen intent to bolster drug supply resiliency. Standing together with our members and in collaboration with stakeholders across the supply chain, our commitment to protect providers and patients from pharmaceutical supply disruption will never waiver. 

Complete the form to download the thesis paper today.